Update: 25.12.2024
Last week: 49 week 2024 (09.12.2024 - 15.12.2024)
Last full month: November 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 940 | 0.7% | 14.0% | 0.4 | 18 661 755 | 2.5% | 9.8% | 0.4 | -2.3% |
| MoM | 44 632 | -3.6% | 13.3% | -0.2 | 78 965 673 | 0.5% | 8.9% | 0.2 | -2.0% |
| YTD | 394 717 | 23.1% | 12.3% | 3.2 | 787 499 623 | 28.3% | 9.3% | 1.6 | -8.6% |
| MAT | 414 903 | 22.8% | 12.1% | 3 | 830 641 564 | 28.8% | 9.2% | 1.6 | -7.8% |
| BRAINMAX | |||||||||
| WoW | 2 351 | -1.8% | 100.0% | 0 | 8 017 457 | 0.8% | 100.0% | 0 | -1.8% |
| MoM | 11 703 | 2.1% | 100.0% | 0 | 38 888 035 | -0.2% | 100.0% | 0 | 2.1% |
| YTD | 75 704 | 76.0% | 100.0% | 0 | 262 815 261 | 77.3% | 100.0% | 0 | 76.0% |
| MAT | 79 344 | 77.5% | 100.0% | 0 | 275 595 210 | 79.4% | 100.0% | 0 | 77.5% |
| GOLDLINE PLUS | |||||||||
| WoW | 13 482 | -2.4% | 46.4% | -1.1 | 42 435 257 | -0.8% | 38.0% | -0.7 | -0.1% |
| MoM | 62 745 | -4.1% | 47.4% | 1.3 | 195 756 051 | -3.4% | 38.7% | 0.9 | -6.7% |
| YTD | 787 812 | -4.7% | 45.4% | 0.5 | 2 472 077 793 | -3.2% | 37.1% | -2.6 | -5.7% |
| MAT | 829 979 | -3.8% | 45.4% | 0.6 | 2 610 466 554 | -1.7% | 37.2% | -2.4 | -5.0% |
| MIGRENIUM | |||||||||
| WoW | 7 561 | -14.8% | 0.4% | -0.1 | 2 641 894 | -13.1% | 0.5% | -0.1 | -1.6% |
| MoM | 41 128 | 0.4% | 0.4% | 0 | 14 076 174 | 0.9% | 0.6% | 0.1 | -9.7% |
| YTD | 541 807 | -10.9% | 0.5% | -0.1 | 172 556 240 | 50.2% | 0.6% | 0.2 | 5.1% |
| MAT | 575 172 | -11.7% | 0.5% | -0.1 | 180 308 465 | 47.1% | 0.6% | 0.1 | 6.3% |
| MODELAX-N | |||||||||
| WoW | 26 827 | -4.3% | 19.5% | -1.2 | 13 484 700 | -3.6% | 13.6% | -0.6 | 1.8% |
| MoM | 119 981 | 0.2% | 20.6% | 0.4 | 59 442 550 | 4.1% | 13.8% | 0.6 | -2.0% |
| YTD | 1 384 310 | 25.7% | 22.0% | 3.2 | 618 848 646 | 73.0% | 14.3% | 3.8 | 7.6% |
| MAT | 1 450 778 | 26.6% | 21.6% | 3.1 | 643 907 083 | 72.7% | 14.0% | 3.7 | 8.6% |
| REDUXIN | |||||||||
| WoW | 9 333 | 1.2% | 32.1% | 0.4 | 49 345 061 | 2.0% | 44.2% | 0.5 | -0.1% |
| MoM | 41 852 | -9.0% | 31.6% | -0.8 | 222 036 149 | -6.5% | 43.9% | -0.4 | -6.7% |
| YTD | 567 771 | -6.8% | 32.7% | -0.4 | 3 012 668 162 | 10.5% | 45.2% | 2.9 | -5.7% |
| MAT | 596 251 | -6.4% | 32.6% | -0.5 | 3 160 084 865 | 11.5% | 45.1% | 2.8 | -5.0% |
| REDUXIN FORTE | |||||||||
| WoW | 2 816 | 3.3% | 9.7% | 0.3 | 12 277 229 | 1.7% | 11.0% | 0.1 | -0.1% |
| MoM | 12 608 | -9.7% | 9.5% | -0.3 | 53 587 719 | -9.2% | 10.6% | -0.4 | -6.7% |
| YTD | 158 886 | 0.9% | 9.1% | 0.6 | 683 695 716 | 11.1% | 10.3% | 0.7 | -5.7% |
| MAT | 167 404 | 1.4% | 9.2% | 0.6 | 721 595 548 | 12.0% | 10.3% | 0.7 | -5.0% |
| SALVISAR | |||||||||
| WoW | 12 540 | -3.3% | 1.8% | 0 | 5 680 900 | -1.9% | 1.7% | 0 | -2.8% |
| MoM | 65 206 | 11.6% | 2.0% | 0.3 | 28 985 629 | 13.4% | 1.8% | 0.3 | -7.2% |
| YTD | 531 747 | 12.5% | 1.5% | 0.2 | 222 814 297 | 43.6% | 1.3% | 0.3 | -3.4% |
| MAT | 557 645 | 9.4% | 1.4% | 0.2 | 231 395 814 | 37.9% | 1.3% | 0.2 | -2.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 394 717 | 23.1% | 12.3% | 3.2 | 787 499 623 | 28.3% | 9.3% | 1.6 | -8.6% |
| BRAINMAX | 75 704 | 76.0% | 100.0% | 0 | 262 815 261 | 77.3% | 100.0% | 0 | 76.0% |
| GOLDLINE PLUS | 787 812 | -4.7% | 45.4% | 0.5 | 2 472 077 793 | -3.2% | 37.1% | -2.6 | -5.7% |
| MIGRENIUM | 541 807 | -10.9% | 0.5% | -0.1 | 172 556 240 | 50.2% | 0.6% | 0.2 | 5.1% |
| MODELAX-N | 1 384 310 | 25.7% | 22.0% | 3.2 | 618 848 646 | 73.0% | 14.3% | 3.8 | 7.6% |
| REDUXIN CAPS | 567 771 | -6.8% | 32.7% | -0.4 | 3 012 668 162 | 10.5% | 45.2% | 2.9 | -5.7% |
| REDUXIN FORTE | 158 886 | 0.9% | 9.1% | 0.6 | 683 695 716 | 11.1% | 10.3% | 0.7 | -5.7% |
| SALVISAR | 531 747 | 12.5% | 1.5% | 0.2 | 222 814 297 | 43.6% | 1.3% | 0.3 | -3.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 414 903 | 22.8% | 12.1% | 3 | 830 641 564 | 28.8% | 9.2% | 1.6 | -7.8% |
| BRAINMAX | 79 344 | 77.5% | 100.0% | 0 | 275 595 210 | 79.4% | 100.0% | 0 | 77.5% |
| GOLDLINE PLUS | 829 979 | -3.8% | 45.4% | 0.6 | 2 610 466 554 | -1.7% | 37.2% | -2.4 | -5.0% |
| MIGRENIUM | 575 172 | -11.7% | 0.5% | -0.1 | 180 308 465 | 47.1% | 0.6% | 0.1 | 6.3% |
| MODELAX-N | 1 450 778 | 26.6% | 21.6% | 3.1 | 643 907 083 | 72.7% | 14.0% | 3.7 | 8.6% |
| REDUXIN CAPS | 596 251 | -6.4% | 32.6% | -0.5 | 3 160 084 865 | 11.5% | 45.1% | 2.8 | -5.0% |
| REDUXIN FORTE | 167 404 | 1.4% | 9.2% | 0.6 | 721 595 548 | 12.0% | 10.3% | 0.7 | -5.0% |
| SALVISAR | 557 645 | 9.4% | 1.4% | 0.2 | 231 395 814 | 37.9% | 1.3% | 0.2 | -2.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 940 | 0.7% | 14.0% | 0.4 | 18 661 755 | 2.5% | 9.8% | 0.4 | -2.3% |
| BRAINMAX | 2 351 | -1.8% | 100.0% | 0 | 8 017 457 | 0.8% | 100.0% | 0 | -1.8% |
| GOLDLINE PLUS | 13 482 | -2.4% | 46.4% | -1.1 | 42 435 257 | -0.8% | 38.0% | -0.7 | -0.1% |
| MIGRENIUM | 7 561 | -14.8% | 0.4% | -0.1 | 2 641 894 | -13.1% | 0.5% | -0.1 | -1.6% |
| MODELAX-N | 26 827 | -4.3% | 19.5% | -1.2 | 13 484 700 | -3.6% | 13.6% | -0.6 | 1.8% |
| REDUXIN CAPS | 9 333 | 1.2% | 32.1% | 0.4 | 49 345 061 | 2.0% | 44.2% | 0.5 | -0.1% |
| REDUXIN FORTE | 2 816 | 3.3% | 9.7% | 0.3 | 12 277 229 | 1.7% | 11.0% | 0.1 | -0.1% |
| SALVISAR | 12 540 | -3.3% | 1.8% | 0 | 5 680 900 | -1.9% | 1.7% | 0 | -2.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 44 632 | -3.6% | 13.3% | -0.2 | 78 965 673 | 0.5% | 8.9% | 0.2 | -2.0% |
| BRAINMAX | 11 703 | 2.1% | 100.0% | 0 | 38 888 035 | -0.2% | 100.0% | 0 | 2.1% |
| GOLDLINE PLUS | 62 745 | -4.1% | 47.4% | 1.3 | 195 756 051 | -3.4% | 38.7% | 0.9 | -6.7% |
| MIGRENIUM | 41 128 | 0.4% | 0.4% | 0 | 14 076 174 | 0.9% | 0.6% | 0.1 | -9.7% |
| MODELAX-N | 119 981 | 0.2% | 20.6% | 0.4 | 59 442 550 | 4.1% | 13.8% | 0.6 | -2.0% |
| REDUXIN CAPS | 41 852 | -9.0% | 31.6% | -0.8 | 222 036 149 | -6.5% | 43.9% | -0.4 | -6.7% |
| REDUXIN FORTE | 12 608 | -9.7% | 9.5% | -0.3 | 53 587 719 | -9.2% | 10.6% | -0.4 | -6.7% |
| SALVISAR | 65 206 | 11.6% | 2.0% | 0.3 | 28 985 629 | 13.4% | 1.8% | 0.3 | -7.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
*****
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs